文獻(xiàn)標(biāo)題:
1.Development and evaluation of chitosan based oral controlled matrix tablets of?losartan?potassium
J Pharm Investig.?2012 Jul;2(3):157-61. doi: 10.4103/2230-973X.104399.
2.Response criteria of tolvaptan for the treatment of hepatic edema J Gastroenterol. 2017 Jun 29.
3.Hepatol Res.?2017 Oct 6. doi: 10.1111/hepr.12988. [Epub ahead of print]
Increased?serum?C-reactive?protein?and?decreased?urinary?aquaporin?2?levels?are?predictive?of the?efficacy?of?tolvaptan?in?patients?with?liver?cirrhosis.
4.Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range.
5.An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles
6.Anatol J Cardiol.?2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033.
Tolvaptan?in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration.
7.紫外-可見(jiàn)分光光度法測(cè)定依達(dá)拉奉注射液中的亞硫酸氫鈉含量
8.Anatol J Cardiol. 2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033.
Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration.
備注: 將符合要求的文獻(xiàn)PDF格式打包上傳
[更多]
渝公網(wǎng)安備 50010802001068號(hào)
